Pelvic inflammatory disease primary prevention: Difference between revisions
No edit summary |
|||
Line 14: | Line 14: | ||
Any genital symptoms such as an unusual sore, discharge with odor, burning during urination, or bleeding between menstrual cycles could mean an STD infection. If a woman has any of these symptoms, she should stop having sex and consult a health care provider immediately. Treating STDs early can prevent PID. Women who are told they have an STD and are treated for it should notify all of their recent sex partners so they can see a health care provider and be evaluated for STDs. Sexual activity should not resume until all sex partners have been examined and, if necessary, treated. | Any genital symptoms such as an unusual sore, discharge with odor, burning during urination, or bleeding between menstrual cycles could mean an STD infection. If a woman has any of these symptoms, she should stop having sex and consult a health care provider immediately. Treating STDs early can prevent PID. Women who are told they have an STD and are treated for it should notify all of their recent sex partners so they can see a health care provider and be evaluated for STDs. Sexual activity should not resume until all sex partners have been examined and, if necessary, treated. | ||
*Risk reduction against sexually transmitted diseases through [[abstinence]] or barrier methods such as [[condoms]], see | *Risk reduction against sexually transmitted diseases through [[abstinence]] or barrier methods such as [[condoms]], see human sexual behavior for other listings. | ||
*Going to the doctor immediately if symptoms of PID, [[sexually transmitted disease]]s appear, or after learning that a current or former sex partner has, or might have had a sexually transmitted disease. | *Going to the doctor immediately if symptoms of PID, [[sexually transmitted disease]]s appear, or after learning that a current or former sex partner has, or might have had a sexually transmitted disease. | ||
* Getting regular [[Gynecology|gynecological]] (pelvic) exams with [[STD]] testing to screen for symptomless PID. <ref name="pmid17888100">{{cite journal |author=Smith KJ, Cook RL, Roberts MS |title=Time from sexually transmitted infection acquisition to pelvic inflammatory disease development: influence on the cost-effectiveness of different screening intervals |journal=Value Health |volume=10 |issue=5 |pages=358–66 |year=2007 |pmid=17888100 |doi=10.1111/j.1524-4733.2007.00189.x}}</ref> | * Getting regular [[Gynecology|gynecological]] (pelvic) exams with [[STD]] testing to screen for symptomless PID. <ref name="pmid17888100">{{cite journal |author=Smith KJ, Cook RL, Roberts MS |title=Time from sexually transmitted infection acquisition to pelvic inflammatory disease development: influence on the cost-effectiveness of different screening intervals |journal=Value Health |volume=10 |issue=5 |pages=358–66 |year=2007 |pmid=17888100 |doi=10.1111/j.1524-4733.2007.00189.x}}</ref> |
Revision as of 19:47, 27 December 2012
Pelvic inflammatory disease Microchapters |
Differentiating Pelvic Inflammatory Disease from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Pelvic inflammatory disease primary prevention On the Web |
American Roentgen Ray Society Images of Pelvic inflammatory disease primary prevention |
Risk calculators and risk factors for Pelvic inflammatory disease primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Primary Prevention
Women can protect themselves from PID by taking action to prevent STDs or by getting early treatment if they do get an STD.
The surest way to avoid transmission of STDs is to abstain from sexual intercourse, or to be in a long-term mutually monogamous relationship with a partner who has been tested and is known to be uninfected.
Latex male condoms, when used consistently and correctly, can reduce the risk of transmission of chlamydia and gonorrhea.
CDC recommends yearly chlamydia testing of all sexually active women age 25 or younger, older women with risk factors for chlamydial infections (those who have a new sex partner or multiple sex partners), and all pregnant women. An appropriate sexual risk assessment by a health care provider should always be conducted and may indicate more frequent screening for some women.
Any genital symptoms such as an unusual sore, discharge with odor, burning during urination, or bleeding between menstrual cycles could mean an STD infection. If a woman has any of these symptoms, she should stop having sex and consult a health care provider immediately. Treating STDs early can prevent PID. Women who are told they have an STD and are treated for it should notify all of their recent sex partners so they can see a health care provider and be evaluated for STDs. Sexual activity should not resume until all sex partners have been examined and, if necessary, treated.
- Risk reduction against sexually transmitted diseases through abstinence or barrier methods such as condoms, see human sexual behavior for other listings.
- Going to the doctor immediately if symptoms of PID, sexually transmitted diseases appear, or after learning that a current or former sex partner has, or might have had a sexually transmitted disease.
- Getting regular gynecological (pelvic) exams with STD testing to screen for symptomless PID. [1]
- Discussing sexual history with a trusted physician in order to get properly screened for sexually transmitted diseases.
- Regularly scheduling STD testing with a physician and discussing which tests will be performed that session.
- Getting a STD history from your current partner and insisting they be tested and treated before intercourse.
- Understanding when a partner says that they have been STD tested they usually mean chlamydia and gonorrhea in the US, but that those are not all of the sexually transmissible diseases.
- Treating partners so you don't become reinfected or they do not infect another.
References
- ↑ Smith KJ, Cook RL, Roberts MS (2007). "Time from sexually transmitted infection acquisition to pelvic inflammatory disease development: influence on the cost-effectiveness of different screening intervals". Value Health. 10 (5): 358–66. doi:10.1111/j.1524-4733.2007.00189.x. PMID 17888100.